X4 Pharmaceuticals (XFOR) Return on Invested Capital (2020 - 2024)
X4 Pharmaceuticals (XFOR) posted Return on Invested Capital of 1.11% for Q1 2024, down 103.85% on a QoQ basis from 0.54% in Q4 2023, and down 107.0% year-over-year from 15.86% in Q2 2023.
X4 Pharmaceuticals (XFOR) Return on Invested Capital (2020 - 2024) Analysis & Trends
X4 Pharmaceuticals' Return on Invested Capital history runs 5 years deep, the most recent figure standing at 1.11% for Q1 2024.
- Quarterly Return on Invested Capital fell 107.0% year-over-year to 1.11% in Q1 2024, while the trailing twelve-month figure through Mar 2024 was 1.11% (down 107.0% YoY) and the FY2022 annual result came in at 0.83%, changed N/A from the prior year.
- Return on Invested Capital was 1.11% for Q1 2024 at X4 Pharmaceuticals, down from 0.54% in the prior quarter.
- Across five years, Return on Invested Capital topped out at 0.03% in Q4 2022 and bottomed at 1.11% in Q1 2024.
- A 5-year average of 0.29% and a median of 0.1% in 2022 frame the typical range for Return on Invested Capital.
- Annual changes were most pronounced in 2022 — Return on Invested Capital jumped 75 bps — and 2024, when it slumped 107 bps.
- X4 Pharmaceuticals' Return on Invested Capital stood at 0.08% in 2020, then plunged by 921 bps to 0.78% in 2021, then soared by 96 bps to 0.03% in 2022, then tumbled by 1622 bps to 0.54% in 2023, then tumbled by 104 bps to 1.11% in 2024.
- Business Quant data shows XFOR's Return on Invested Capital at 1.11% in Q1 2024, 0.54% in Q4 2023, and 0.11% in Q3 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROIC (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 0.00% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 0.04% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | X4 Pharmaceuticals | 167.90 Mn | -49.15 Mn | 2.20 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | -1.11% |
| Dec 31, 2023 | -0.54% |
| Sep 30, 2023 | -0.11% |
| Jun 30, 2023 | -0.05% |
| Mar 31, 2023 | -0.04% |
| Dec 31, 2022 | -0.03% |
| Sep 30, 2022 | -0.04% |
| Jun 30, 2022 | -0.10% |
| Mar 31, 2022 | -0.28% |
| Dec 31, 2021 | -0.78% |
| Mar 31, 2020 | -0.08% |